Shinohara M
Department of Urology, Faculty of Medicine, University of Tokyo.
Nihon Naibunpi Gakkai Zasshi. 1989 Mar 20;65(3):161-73. doi: 10.1507/endocrine1927.65.3_161.
The STS (steroid sulfatase) gene which has been assigned to the short arm of human X chromosome (band p22) is thought to have escaped from Lyon's inactivation. For that reason, the STS enzyme activities differ between male and female according to the number of X chromosomes in cells. In this report, the STS enzyme activities were studied in different human tissues such as placentas, lymphocytes, and cultured fibroblasts of normal individuals and sex anomaly patients. Tritium labelled dehydroepiandrosterone sulfate (DHA-S) was used as the reaction substrate. The placental STS activities between normal male and female subjects showed a significant difference in spite of wide variances that were ascertained not to be the effects of methodological alterations involving enzyme purification, substrate concentration, and activity calculation (units per mg of protein or DNA). Further, lymphocytes and fibroblasts which had low levels of enzyme concentration compared with placentas, the STS enzyme activities were also significantly different between both sexes. These results confirmed that the STS gene in cells of tissue tested here seemed to be inactive at the gene level and followed the gene dosage effect to some extent. The enzyme activity was also studied in 17 patients with sex anomalies using lymphocytes and cultured fibroblasts. The cells of 45,X Turner Syndrome and of Klinefelter syndrome with 47,XXY or other karyotypes, showed slightly lower levels of enzyme activity when compared with control values of normal males or females. The enzyme activity in intersexual disturbances, especially XX male and XX true hermaphrodites, showed intermediate levels between normal male and female values. This result may give support to the concept that at least one X chromosome in these diseases is genetically abnormal due to X-Y interchanges, something that has been partly proved recently by analysis of H-Y antigen and Y-specific DNA probes. The present study on the STS enzyme activity revealed the presence of a gene dosage effect of STS gene between males and females not precise but rather rough in quantity, and it pointed out problem, some of which were related to genetic and environmental factors modifying the STS gene expression in normal individuals as well as sex anomaly patients.
已被定位于人类X染色体短臂(p22带)的类固醇硫酸酯酶(STS)基因被认为逃脱了莱昂化失活。因此,STS酶活性在男性和女性之间因细胞中X染色体的数量而异。在本报告中,研究了正常个体和性发育异常患者的不同人体组织(如胎盘、淋巴细胞和培养的成纤维细胞)中的STS酶活性。用氚标记的硫酸脱氢表雄酮(DHA-S)作为反应底物。尽管确定正常男性和女性受试者之间胎盘STS活性的广泛差异不是酶纯化、底物浓度和活性计算(每毫克蛋白质或DNA的单位)等方法学改变的影响,但仍显示出显著差异。此外,与胎盘相比酶浓度较低的淋巴细胞和成纤维细胞,两性之间的STS酶活性也有显著差异。这些结果证实,此处测试的组织细胞中的STS基因似乎在基因水平上无活性,并在一定程度上遵循基因剂量效应。还使用淋巴细胞和培养的成纤维细胞研究了17例性发育异常患者的酶活性。与正常男性或女性的对照值相比,45,X特纳综合征以及47,XXY或其他核型的克兰费尔特综合征患者细胞的酶活性略低。两性畸形患者,尤其是XX男性和XX真两性畸形患者的酶活性显示在正常男性和女性值之间的中间水平。这一结果可能支持这样一种概念,即这些疾病中至少有一条X染色体由于X-Y互换而在基因上异常,这一点最近通过对H-Y抗原和Y特异性DNA探针的分析已得到部分证实。目前关于STS酶活性的研究揭示了STS基因在男性和女性之间存在基因剂量效应,虽然数量上不精确但较为粗略,并且指出了一些问题,其中一些与影响正常个体以及性发育异常患者中STS基因表达的遗传和环境因素有关。